Exact Mass: 565.3152

Exact Mass Matches: 565.3152

Found 9 metabolites which its exact mass value is equals to given mass value 565.3152, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Antibiotic FR 900848

C32H43N3O6 (565.3152)

Jawsamycin

C32H43N3O6 (565.3152)

A polyketide that is 5-amino-5-deoxy-3,4,5,6-tetrahydrouridine in which one of the hydrogens of the amino group is substituted by a (1E,3E)-1-[(1R,1R,1R,1R,2S,2R,2R,2S)-2-{(E)-2-[(1R,2R)-2-methylcyclopropyl]ethenyl}[1,1:2,1:2,1-quater(cyclopropan)]-2-yl]-5-oxopenta-1,3-dien-5-yl group. It is a metabolite isolated from the bacterium, Streptoverticillium fervens and targets the catalytic subunit of the fungal UDP-glycosyltransferase, the first step in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors. It exhibits broad spectrum antifungal activity against several pathogenic fungi including Mucorales.

4-[[[(2S,3R)-9-[[cyclohexyl(oxo)methyl]amino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzoic acid

C32H43N3O6 (565.3152)

N-[(5S,6R,9R)-8-[cyclohexyl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-methoxybenzamide

C32H43N3O6 (565.3152)

(2e,4e)-n-{[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1'r,2s)-2'-[(1'r,2r,2's)-2'-[(1e)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

(2e,4e)-n-{[(2r,3s,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1'r,2s)-2'-[(1'r,2r,2's)-2'-[(1e)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

C32H43N3O6 (565.3152)

7'-(3,3-dimethyloxirane-2-carbonyl)-1-formyl-2'-hydroxy-1,6-dimethyl-3a-(methylamino)-4,6,7,8,9,9a,10,10a-octahydro-3h-spiro[cyclopenta[b]quinolizine-2,3'-indol]-8-yl butanoate

C32H43N3O6 (565.3152)

(2e,4e)-n-{[(2s,3s,4r,5s)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1s,1's,2r,2's)-2'-[(1s,1's,2s,2'r)-2'-[(1e)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

(2e,4e)-n-{[(2s,3s,4r,5s)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1s,1's,2r,2's)-2'-[(1s,1's,2s,2'r)-2'-[(1e)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

C32H43N3O6 (565.3152)

(2e,4e)-n-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1r,1'r,2r,2's)-2'-[(1r,1's,2r,2'r)-2'-[(1z)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

(2e,4e)-n-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-5,6-dihydropyrimidin-1-yl)oxolan-2-yl]methyl}-5-[(1r,1'r,2r,2's)-2'-[(1r,1's,2r,2'r)-2'-[(1z)-2-[(1r,2r)-2-methylcyclopropyl]ethenyl]-[1,1'-bi(cyclopropane)]-2-yl]-[1,1'-bi(cyclopropane)]-2-yl]penta-2,4-dienimidic acid

C32H43N3O6 (565.3152)

(1r,2r,3as,6s,8r,9as,10ar)-7'-[(2s)-3,3-dimethyloxirane-2-carbonyl]-1-formyl-2'-hydroxy-1,6-dimethyl-3a-(methylamino)-4,6,7,8,9,9a,10,10a-octahydro-3h-spiro[cyclopenta[b]quinolizine-2,3'-indol]-8-yl butanoate

(1r,2r,3as,6s,8r,9as,10ar)-7'-[(2s)-3,3-dimethyloxirane-2-carbonyl]-1-formyl-2'-hydroxy-1,6-dimethyl-3a-(methylamino)-4,6,7,8,9,9a,10,10a-octahydro-3h-spiro[cyclopenta[b]quinolizine-2,3'-indol]-8-yl butanoate

C32H43N3O6 (565.3152)